The following information is missing from the Funding statement: This study was supported by the Cultivating Fund for National Natural Science Foundation of China of Shandong Provincial Qianfoshan Hospital (QYPY2019NSFC0603).
Reference
- 1. Zhang C, Li W, Li X, Wan D, Mack S, Zhang J, et al. (2022) Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor. PLOS ONE 17(4): e0266608. https://doi.org/10.1371/journal.pone.0266608 pmid:35443010
Citation: Zhang C, Li W, Li X, Wan D, Mack S, Zhang J, et al. (2024) Correction: Novel aerosol treatment of airway hyper-reactivity and inflammation in a murine model of asthma with a soluble epoxide hydrolase inhibitor. PLoS ONE 19(7): e0307533. https://doi.org/10.1371/journal.pone.0307533
Published: July 17, 2024
Copyright: © 2024 Zhang et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.